Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange ArcaEquity ETF
$24.255
−$0.4482 · -1.81%
As of Oct 8, 3:59 PM ET
Regular session · ET · Market data may be delayed.
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Fund facts updated Oct 8, 2026.
Day range
Current $24.255
52-week range
Current $24.255
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
1 month
-7.99%
3 months
-7.85%
Year to date
-3.83%
1 year
-1.48%
Since inception
-4.51%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 22 reported holdings
Displayed portfolio weight: 86.04%
Holdings data updated Oct 8, 2026.
Signed exposures may include leverage or short positions and do not represent ordinary portfolio weights.
Dec 30, 2025
Dec 30, 2025
Dec 31, 2025
$0.4132
Irregular
Dec 30, 2024
Dec 30, 2024
Dec 31, 2024
$0.2199
Annual
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
